SLC28A1
Basic information
Region (hg38): 15:84884654-84945798
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Uridine-cytidineuria | AR | General | The clinical relevance is unclear | Biochemical | 30658162; 30847922 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC28A1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 36 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 37 | 5 | 17 |
Variants in SLC28A1
This is a list of pathogenic ClinVar variants found in the SLC28A1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-84887769-C-T | SLC28A1-related disorder | Benign (Apr 10, 2018) | ||
15-84887830-A-C | not specified | Uncertain significance (Mar 23, 2022) | ||
15-84887831-T-A | not specified | Uncertain significance (Mar 23, 2022) | ||
15-84888762-C-T | SLC28A1-related disorder | Likely benign (Dec 26, 2019) | ||
15-84888799-T-C | SLC28A1-related disorder | Benign (Nov 08, 2019) | ||
15-84888803-G-A | SLC28A1-related disorder | Benign (Nov 13, 2019) | ||
15-84888842-C-G | not specified | Uncertain significance (Jan 02, 2024) | ||
15-84888842-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
15-84890532-C-T | not specified | Uncertain significance (Apr 18, 2024) | ||
15-84894964-C-T | not specified | Uncertain significance (Dec 07, 2023) | ||
15-84894993-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
15-84895038-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
15-84895048-A-C | not specified | Uncertain significance (Mar 24, 2023) | ||
15-84895080-C-CTTG | SLC28A1-related disorder | Benign (Oct 30, 2019) | ||
15-84895099-C-T | not specified | Uncertain significance (May 07, 2024) | ||
15-84895102-G-A | SLC28A1-related disorder | Likely benign (Jan 01, 2023) | ||
15-84895110-C-A | not specified | Uncertain significance (Aug 13, 2021) | ||
15-84895420-C-G | SLC28A1-related disorder | Likely benign (Nov 25, 2019) | ||
15-84904099-G-T | not specified | Uncertain significance (Jan 16, 2024) | ||
15-84904147-A-G | not specified | Uncertain significance (Nov 07, 2023) | ||
15-84904159-G-A | not specified | Uncertain significance (Apr 16, 2024) | ||
15-84904200-G-A | SLC28A1-related disorder | Benign (Oct 30, 2019) | ||
15-84904203-G-T | SLC28A1-related disorder | Benign (Nov 08, 2019) | ||
15-84904227-C-T | not specified | Uncertain significance (May 03, 2023) | ||
15-84904236-G-A | not specified | Uncertain significance (May 11, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC28A1 | protein_coding | protein_coding | ENST00000394573 | 17 | 90992 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.74e-20 | 0.00607 | 125343 | 2 | 403 | 125748 | 0.00161 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.742 | 393 | 354 | 1.11 | 0.0000224 | 4184 |
Missense in Polyphen | 136 | 138.77 | 0.98004 | 1740 | ||
Synonymous | -1.65 | 177 | 151 | 1.17 | 0.0000105 | 1331 |
Loss of Function | 0.389 | 31 | 33.4 | 0.927 | 0.00000174 | 361 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0150 | 0.0149 |
Ashkenazi Jewish | 0.000992 | 0.000993 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.000101 | 0.0000924 |
European (Non-Finnish) | 0.000406 | 0.000404 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.00242 | 0.00242 |
Other | 0.00130 | 0.00130 |
dbNSFP
Source:
- Function
- FUNCTION: Sodium-dependent and pyrimidine-selective. Exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) (selective for pyrimidine nucleosides and adenosine). It also transports the antiviral pyrimidine nucleoside analogs 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxycytidine (ddC). It may be involved in the intestinal absorption and renal handling of pyrimidine nucleoside analogs used to treat acquired immunodeficiency syndrome (AIDS). It has the following selective inhibition: adenosine, thymidine, cytidine, uridine >> guanosine, inosine.;
- Pathway
- Zidovudine Pathway, Pharmacokinetics/Pharmacodynamics;Gemcitabine Pathway, Pharmacodynamics;Capecitabine Action Pathway;Capecitabine Metabolism Pathway;Gemcitabine Action Pathway;Gemcitabine Metabolism Pathway;Purine metabolism;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of small molecules;Pyrimidine metabolism;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
(Consensus)
Recessive Scores
- pRec
- 0.171
Intolerance Scores
- loftool
- 0.876
- rvis_EVS
- 0.76
- rvis_percentile_EVS
- 86.85
Haploinsufficiency Scores
- pHI
- 0.0673
- hipred
- N
- hipred_score
- 0.154
- ghis
- 0.411
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.247
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Slc28a1
- Phenotype
Gene ontology
- Biological process
- nucleobase-containing compound metabolic process;pyrimidine nucleobase transport;nucleoside transport;pyrimidine-containing compound transmembrane transport;nucleoside transmembrane transport;purine nucleobase transmembrane transport
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane
- Molecular function
- nucleoside transmembrane transporter activity;nucleoside:sodium symporter activity;pyrimidine- and adenine-specific:sodium symporter activity